Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Muggia

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!David S Alberts, Maurie Markman, Deborah Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical studyHayley M McDaid, Sridhar Mani, Heng-Jia Shen, et al.
Ecancermedicalscience|June 19, 2018
Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositisIsabella Cadena, Victoria P Werth, Pascale Levine, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancerEleni Andreopoulou, Thomas Chen, Leonard Liebes, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysisIvan Diaz-Padilla, Nuria Romero, Eitan Amir, et al.
Chemotherapy|May 20, 2009
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanomaPatrick A Ott, Jason L Chang, Ruth Oratz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 7, 2002
Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancerElliot Newman, Stuart G Marcus, Milan Potmesil, et al.
Gynecologic Oncology|March 30, 2004
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancerMichael V Seiden, Franco Muggia, Allan Astrow, et al.
Cancer Chemotherapy and Pharmacology|April 14, 2019
Neoadjuvant chemotherapy in patients with advanced endometrial cancerOlivia R Khouri, Melissa K Frey, Fernanda Musa, et al.
Gynecologic Oncology|March 30, 2004
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group studyFarr Nezhat, Scott Wadler, Franco Muggia, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!David S Alberts, Maurie Markman, Deborah Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical studyHayley M McDaid, Sridhar Mani, Heng-Jia Shen, et al.
Ecancermedicalscience|June 19, 2018
Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositisIsabella Cadena, Victoria P Werth, Pascale Levine, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancerEleni Andreopoulou, Thomas Chen, Leonard Liebes, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysisIvan Diaz-Padilla, Nuria Romero, Eitan Amir, et al.
Chemotherapy|May 20, 2009
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanomaPatrick A Ott, Jason L Chang, Ruth Oratz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 7, 2002
Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancerElliot Newman, Stuart G Marcus, Milan Potmesil, et al.
Gynecologic Oncology|March 30, 2004
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancerMichael V Seiden, Franco Muggia, Allan Astrow, et al.
Cancer Chemotherapy and Pharmacology|April 14, 2019
Neoadjuvant chemotherapy in patients with advanced endometrial cancerOlivia R Khouri, Melissa K Frey, Fernanda Musa, et al.
Gynecologic Oncology|March 30, 2004
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group studyFarr Nezhat, Scott Wadler, Franco Muggia, et al.
Pageof 10